Back to Journals » Clinical Ophthalmology » Volume 7

Efficacy of reduced-fluence photodynamic therapy for serous retinal pigment epithelial detachment with choroidal hyperpermeability

Authors Shibata A, Ohkuma Y, Hayashi T, Tsuneoka H

Received 4 August 2013

Accepted for publication 5 September 2013

Published 30 October 2013 Volume 2013:7 Pages 2123—2126


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Asako Shibata, Yasuhiro Ohkuma, Takaaki Hayashi, Hiroshi Tsuneoka

Department of Ophthalmology, The Jikei University School of Medicine, Tokyo, Japan

Background: Very few reports have addressed methods of treatment for idiopathic serous (IS) pigment epithelial detachment (PED).
Objective: The purpose of this report was to describe clinical courses of two patients with ISPED in whom reduced-fluence photodynamic therapy (RFPDT) was performed.
Case reports: Two patients (a 38-year-old woman and a 42-year-old man) were diagnosed with ISPED. In both patients, indocyanine green angiography revealed an area of choroidal vascular hyperpermeability including hyperfluorescent PED, which was evident at the subfoveal area. Both patients underwent RFPDT at an energy of 25 J/cm2. The PED was seen to have resolved 1 month after the treatment and visual acuity was maintained or improved. There was no posttreatment recurrence of PED after 6 months to 1 year, and no treatment-related adverse events were observed.
Conclusion: RFPDT may be an effective and safe method of treatment for ISPED with choroidal vascular hyperpermeability.

Keywords: pigment epithelial detachment, central serous chorioretinopathy, reduced-fluence photodynamic therapy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]